13F
中

NVCT NUVECTIS PHARMA INC

2026Q1 · CUSIP 67080T108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
60
Δ holders QoQ
+13
Breadth percentile
Top 23%
Whale holders
33
Δ whales
+7
Inst. holding value
$35M
New positions
17
Closed positions
4
Price momentum (1Q)
—
Put / Call
0/1

Breadth history (34 quarters)

2022Q2: Δ+3 · h=12 2022Q3: Δ+1 · h=13 2022Q4: Δ-1 · h=12 2023Q1: Δ+2 · h=14 2023Q2: Δ+23 · h=37 2023Q3: Δ-4 · h=33 2023Q4: Δ+3 · h=36 2024Q1: Δ+4 · h=40 2024Q2: Δ+1 · h=41 2024Q3: Δ-10 · h=31 2024Q4: Δ+0 · h=31 2025Q1: Δ+2 · h=33 2025Q2: Δ+13 · h=46 2025Q3: Δ+7 · h=53 2025Q4: Δ-6 · h=47 2026Q1: Δ+13 · h=60 2022Q2: holders=12 2022Q3: holders=13 2022Q4: holders=12 2023Q1: holders=14 2023Q2: holders=37 2023Q3: holders=33 2023Q4: holders=36 2024Q1: holders=40 2024Q2: holders=41 2024Q3: holders=31 2024Q4: holders=31 2025Q1: holders=33 2025Q2: holders=46 2025Q3: holders=53 2025Q4: holders=47 2026Q1: holders=60 -23 -11.5 +0 +11.5 +23 103763 22Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q2 Top 9% — —

Options Sentiment

Put holders
0
QoQ: -2
Call holders
1
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.31
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.28 2022-09-30: EPS -0.42 2022-12-31: EPS -0.49 2023-03-31: EPS -0.27 2023-06-30: EPS -0.38 2023-09-30: EPS -0.37 2023-12-31: EPS -0.41 2024-03-31: EPS -0.25 2024-06-30: EPS -0.26 2024-09-30: EPS -0.24 2024-12-31: EPS -0.36 2025-03-31: EPS -0.27 2025-06-30: EPS -0.30 2025-09-30: EPS -0.44 2025-12-31: EPS -0.31 2026-03-31: EPS -0.26 -0.54 -0.27 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)